252.15(5)(a)(a) An individual who is the subject of a test for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV or the individual's health care agent, if the individual has executed a power of attorney for health care instrument under
ch. 155 and has been found to be incapacitated under
s. 155.05 (2), may disclose the results of the individual's test to anyone. A person who is neither the individual nor the individual's health care agent may not, unless he or she is specifically authorized by the individual to do so, disclose the individual's test results except to the following persons or under the following circumstances:
252.15(5)(a)1.
1. To the subject of the test and, if the test subject has executed a power of attorney for health care instrument under
ch. 155 and has been found to be incapacitated under
s. 155.05 (2), the health care agent.
252.15(5)(a)2.
2. To a health care provider who provides care to the test subject, including those instances in which a health care provider provides emergency care to the subject.
252.15(5)(a)3.
3. To an agent or employe of a health care provider under
subd. 2. who prepares or stores patient health care records, as defined in
s. 146.81 (4), for the purposes of preparation or storage of those records; provides patient care; or handles or processes specimens of body fluids or tissues.
252.15(5)(a)4.
4. To a blood bank, blood center or plasma center that subjects a person to a test under
sub. (2) (a), for any of the following purposes:
252.15(5)(a)4.a.
a. Determining the medical acceptability of blood or plasma secured from the test subject.
252.15(5)(a)5.
5. To a health care provider who procures, processes, distributes or uses a human body part donated as specified under
s. 157.06 (6) (a) or
(b), for the purpose of assuring medical acceptability of the gift for the purpose intended.
252.15(5)(a)6.
6. To the state epidemiologist or his or her designee, for the purpose of providing epidemiologic surveillance or investigation or control of communicable disease.
252.15(5)(a)7.
7. To a funeral director, as defined under
s. 445.01 (5) or to other persons who prepare the body of a decedent for burial or other disposition or to a person who performs an autopsy or assists in performing an autopsy.
252.15(5)(a)8.
8. To health care facility staff committees or accreditation or health care services review organizations for the purposes of conducting program monitoring and evaluation and health care services reviews.
252.15(5)(a)10.
10. To a person who conducts research, for the purpose of research, if the researcher:
252.15(5)(a)10.b.
b. Has obtained permission to perform the research from an institutional review board.
252.15(5)(a)10.c.
c. Provides written assurance to the person disclosing the test results that use of the information requested is only for the purpose under which it is provided to the researcher, the information will not be released to a person not connected with the study, and the final research product will not reveal information that may identify the test subject unless the researcher has first received informed consent for disclosure from the test subject.
252.15(5)(a)11.
11. To a person, including a person exempted from civil liability under the conditions specified under
s. 895.48, who renders to the victim of an emergency or accident emergency care during the course of which the emergency caregiver is significantly exposed to the emergency or accident victim, if a physician, based on information provided to the physician, determines and certifies in writing that the emergency caregiver has been significantly exposed and if the certification accompanies the request for disclosure.
252.15(5)(a)12.
12. To a coroner, medical examiner or an appointed assistant to a coroner or medical examiner, if one or more of the following conditions exist:
252.15(5)(a)12.a.
a. The possible HIV-infected status is relevant to the cause of death of a person whose death is under direct investigation by the coroner, medical examiner or appointed assistant.
252.15(5)(a)12.b.
b. The coroner, medical examiner or appointed assistant is significantly exposed to a person whose death is under direct investigation by the coroner, medical examiner or appointed assistant, if a physician, based on information provided to the physician, determines and certifies in writing that the coroner, medical examiner or appointed assistant has been significantly exposed and if the certification accompanies the request for disclosure.
252.15(5)(a)13.
13. To a sheriff, jailer or keeper of a prison, jail or house of correction or a person designated with custodial authority by the sheriff, jailer or keeper, for whom disclosure is necessitated in order to permit the assigning of a private cell to a prisoner who has a positive test result.
252.15(5)(a)14.
14. If the test results of a test administered to an individual are positive and the individual is deceased, by the individual's attending physician, to persons, if known to the physician, with whom the individual has had sexual contact or has shared intravenous drug use paraphernalia.
252.15(5)(a)15.
15. To anyone who provides consent for the testing under
sub. (2) (a) 4. b., except that disclosure may be made under this subdivision only during a period in which the test subject is adjudicated incompetent under
ch. 880, is under 14 years of age or is unable to communicate due to a medical condition.
252.15(5)(a)17.
17. To an alleged victim or victim, to a health care professional, upon request as specified in
s. 938.296 (4) (e) or
968.38 (4) (c), who provides care to the alleged victim or victim and, if the alleged victim or victim is a minor, to the parent or guardian of the alleged victim or victim, under
s. 938.296 (4) or
968.38 (4).
252.15(5)(a)19.
19. If the test was administered to a child who has been placed in a foster home, treatment foster home, group home or child caring institution, including a placement under
s. 48.205,
48.21,
938.205 or
938.21 or for whom placement in a foster home, treatment foster home, group home or child caring institution is recommended under
s. 48.33 (4),
48.425 (1) (g),
48.837 (4) (c) or
938.33 (3) or
(4), to an agency directed by a court to prepare a court report under
s. 48.33 (1),
48.424 (4) (b),
48.425 (3),
48.831 (2),
48.837 (4) (c) or
938.33 (1), to an agency responsible for preparing a court report under
s. 48.365 (2g),
48.425 (1),
48.831 (2),
48.837 (4) (c) or
938.365 (2g), to an agency responsible for preparing a permanency plan under
s. 48.355 (2e),
48.38,
48.43 (1) (c) or
(5) (c),
48.63 (4),
48.831 (4) (e),
938.355 (2e) or
938.38 regarding the child or to an agency that placed the child or arranged for the placement of the child in any of those placements and, by any of those agencies, to any other of those agencies and, by the agency that placed the child or arranged for the placement of the child in any of those placements, to the child's foster parent or treatment foster parent or the operator of the group home or child caring institution in which the child is placed, as provided in
s. 48.371 or
938.371.
252.15(5)(b)
(b) A private pay patient may deny access to disclosure of his or her test results granted under
par. (a) 10. if he or she annually submits to the maintainer of his or her test results under
sub. (4) (c) a signed, written request that denial be made.
252.15(5m)
(5m) Autopsies; testing of certain corpses. Notwithstanding
s. 157.05, a corpse may be subjected to a test for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV and the test results disclosed to the person who has been significantly exposed under any of the following conditions:
252.15(5m)(a)
(a) If a person, including a person exempted from civil liability under the conditions specified under
s. 895.48, who renders to the victim of an emergency or accident emergency care during the course of which the emergency caregiver is significantly exposed to the emergency or accident victim and the emergency or accident victim subsequently dies prior to testing for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV, and if a physician, based on information provided to the physician, determines and certifies in writing that the emergency caregiver has been significantly exposed and if the certification accompanies the request for testing and disclosure. Testing of a corpse under this paragraph shall be ordered by the coroner, medical examiner or physician who certifies the victim's cause of death under
s. 69.18 (2) (b),
(c) or
(d).
252.15(5m)(b)
(b) If a funeral director, coroner, medical examiner or appointed assistant to a coroner or medical examiner who prepares the corpse of a decedent for burial or other disposition or a person who performs an autopsy or assists in performing an autopsy is significantly exposed to the corpse, and if a physician, based on information provided to the physician, determines and certifies in writing that the funeral director, coroner, medical examiner or appointed assistant has been significantly exposed and if the certification accompanies the request for testing and disclosure. Testing of a corpse under this paragraph shall be ordered by the attending physician of the funeral director, coroner, medical examiner or appointed assistant who is so exposed.
252.15(5m)(c)
(c) If a health care provider or an agent or employe of a health care provider is significantly exposed to the corpse or to a patient who dies subsequent to the exposure and prior to testing for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV, and if a physician who is not the health care provider, based on information provided to the physician, determines and certifies in writing that the health care provider, agent or employe has been significantly exposed and if the certification accompanies the request for testing and disclosure. Testing of a corpse under this paragraph shall be ordered by the physician who certifies that the significant exposure has occurred.
252.15(5r)
(5r) Sale of tests without approval prohibited. No person may sell or offer to sell in this state a test or test kit to detect the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV for self-use by an individual unless the test or test kit is first approved by the state epidemiologist. In reviewing a test or test kit under this subsection, the state epidemiologist shall consider and weigh the benefits, if any, to the public health of the test or test kit against the risks, if any, to the public health of the test or test kit.
252.15(6)
(6) Expanded disclosure of test results prohibited. No person to whom the results of a test for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV have been disclosed under
sub. (5) (a) or
(5m) may disclose the test results except as authorized under
sub. (5) (a) or
(5m).
252.15(7)
(7) Reporting of positive test results. 252.15(7)(a)(a) Notwithstanding
ss. 227.01 (13) and
227.10 (1), for the purposes of this subsection, the state epidemiologist shall determine, based on the preponderance of available scientific evidence, the procedures necessary in this state to obtain a validated test result and the secretary shall so declare under
s. 250.04 (1) or
(2) (a). The state epidemiologist shall revise this determination if, in his or her opinion, changed available scientific evidence warrants a revision, and the secretary shall declare the revision under
s. 250.04 (1) or
(2) (a).
252.15(7)(b)
(b) If a positive, validated test result is obtained from a test subject, the health care provider, blood bank, blood center or plasma center that maintains a record of the test results under
sub. (4) (c) shall report to the state epidemiologist the following information:
252.15(7)(b)1.
1. The name and address of the health care provider, blood bank, blood center or plasma center reporting.
252.15(7)(b)2.
2. The name and address of the subject's health care provider, if known.
252.15(7)(b)3.
3. The name, address, telephone number, age or date of birth, race and ethnicity, sex and county of residence of the test subject, if known.
252.15(7)(b)6.
6. Any other medical or epidemiological information required by the state epidemiologist for the purpose of exercising surveillance, control and prevention of HIV infections.
252.15(7)(c)
(c) A report made under
par. (b) may not include any of the following:
252.15(7)(c)1.
1. Information with respect to the sexual orientation of the test subject.
252.15(7)(c)2.
2. The identity of persons with whom the test subject may have had sexual contact.
252.15(7)(d)
(d) This subsection does not apply to the reporting of information under
s. 252.05 with respect to persons for whom a diagnosis of acquired immunodeficiency syndrome has been made.
252.15(8)(a)(a) Any person violating
sub. (2),
(5) (a),
(5m),
(6) or
(7) (c) is liable to the subject of the test for actual damages and costs, plus exemplary damages of up to $1,000 for a negligent violation and up to $5,000 for an intentional violation.
252.15(9)
(9) Criminal penalty. Whoever intentionally discloses the results of a blood test in violation of
sub. (2) (a) 7m.,
(5) (a) or
(5m) and thereby causes bodily harm or psychological harm to the subject of the test may be fined not more than $10,000 or imprisoned not more than 9 months or both.
252.15 History
History: 1985 a. 29,
73,
120;
1987 a. 70 ss.
13 to
27,
36;
1987 a. 403 ss.
136,
256;
1989 a. 200;
1989 a. 201 ss.
11 to
25,
36;
1989 a. 298,
359;
1991 a. 269;
1993 a. 16 s.
2567;
1993 a. 27 ss.
332,
334,
337,
340,
342; Stats. 1993 s. 252.15;
1993 a. 32,
183,
190,
252,
395,
491;
1995 a. 27 ss.
6323,
9116 (5),
9126 (19);
1995 a. 77,
275.
252.15 Annotation
No claim for violation of (2) was stated where the defendants neither conducted HIV tests nor were authorized recipients of the test results. Hillman v. Columbia County, 164 W (2d) 376, 474 NW (2d) 913 (Ct. App. 1991).
252.15 Annotation
This section does not prevent a court acting in equity from ordering an HIV test where this section does not apply. Syring v. Tucker, 174 W (2d) 787, 498 NW (2d) 370 (1993).
252.15 Annotation
Confidentiality of Medical Records. Meili. Wis. Law. Feb. 1995.
252.16
252.16
Continuation coverage premium subsidies. 252.16(1)(b)
(b) "Group health plan" means an insurance policy or a partially or wholly uninsured plan or program, that provides hospital, medical or other health coverage to members of a group.
252.16(1)(e)
(e) "Residence" means the concurrence of physical presence with intent to remain in a place of fixed habitation. Physical presence is prima facie evidence of intent to remain.
252.16(2)
(2) Subsidy program. From the appropriation under
s. 20.435 (1) (am), the department shall distribute funding in each fiscal year to subsidize the premium costs under
s. 252.17 (2) and, under this subsection, the premium costs for continuation coverage available to an individual who has HIV infection and who is unable to continue his or her employment or must reduce his or her hours because of an illness or medical condition arising from or related to HIV infection.
252.16(3)
(3) Eligibility. An individual is eligible to receive a subsidy in an amount determined under
sub. (4), if the department determines that the individual meets all of the following criteria:
252.16(3)(b)
(b) Has a family income, as defined by rule under
sub. (6), that does not exceed 200% of the federal poverty line, as defined under
42 USC 9902 (2), for a family the size of the individual's family.
252.16(3)(c)
(c) Has submitted to the department a certification from a physician, as defined in
s. 448.01 (5), of all of the following:
252.16(3)(c)1.
1. That the individual has an infection that is an HIV infection.
252.16(3)(c)2.
2. That the individual's employment has terminated or his or her hours have been reduced, because of an illness or medical condition arising from or related to the individual's HIV infection.
252.16(3)(e)
(e) Authorizes the department, in writing, to do all of the following:
252.16(3)(e)1.
1. Contact the individual's former employer or the administrator of the group health plan under which the individual is covered, to verify the individual's eligibility for continuation coverage and the premium and any other conditions of coverage, to make premium payments as provided in
sub. (4) and for other purposes related to the administration of this section.
252.16(3)(e)2.
2. Make any necessary disclosure to the individual's former employer or the administrator of the group health plan under which the individual is covered regarding the individual's HIV status.
252.16(3)(f)
(f) Is not covered by a group health plan other than any of the following:
252.16(3)(f)1.
1. The group health plan under which the individual is eligible for continuation coverage.
252.16(3)(f)2.
2. A group health plan that offers a substantial reduction in covered health care services from the group health plan under
subd. 1.
252.16(3)(g)
(g) Is not covered by an individual health insurance policy other than an individual health insurance policy that offers a substantial reduction in covered health care services from the group health plan under
par. (f) 1.
252.16(4)(a)(a) Except as provided in
pars. (b) and
(c), if an individual satisfies
sub. (3), the department shall pay the full amount of each premium payment for continuation coverage that is due from the individual under
s. 632.897 (2) (d),
29 USC 1162 (3) or
42 USC 300bb-2 (3), whichever is applicable, on or after the date on which the individual becomes eligible for a subsidy under
sub. (3). The department may not refuse to pay the full amount of each premium payment because the continuation coverage that is available to the individual who satisfies
sub. (3) includes coverage of the individual's spouse and dependents. Except as provided in
par. (b), the department shall terminate the payments under this section when the individual's continuation coverage ceases, when the individual no longer satisfies
sub. (3) or upon the expiration of 29 months after the continuation coverage began, whichever occurs first. The department may not make payments under this section for premiums for a conversion policy or plan that is available to an individual under
s. 632.897 (4) or
(6),
29 USC 1162 (5) or
42 USC 300bb-2 (5).
252.16(4)(b)
(b) The obligation of the department to make payments under this section is subject to the availability of funds in the appropriation under
s. 20.435 (1) (am).
252.16(5)
(5) Application process. The department may establish, by rule, a procedure under which an individual who does not satisfy
sub. (3) (b),
(c) 2. or
(d) may submit to the department an application for a premium subsidy under this section that the department shall hold until the individual satisfies each requirement of
sub. (3), if the department determines that the procedure will assist the department to make premium payments in a timely manner once the individual satisfies each requirement of
sub. (3). If an application is submitted by an employed individual under a procedure established by rule under this subsection, the department may not contact the individual's employer or the administrator of the group health plan under which the individual is covered, unless the individual authorizes the department, in writing, to make that contact and to make any necessary disclosure to the individual's employer or the administrator of the group health plan under which the individual is covered regarding the individual's HIV status.
252.16(6)
(6) Rules. The department shall promulgate rules that do all of the following:
252.16(6)(b)
(b) Establish a procedure for making payments under this section that ensures that the payments are actually used to pay premiums for continuation coverage available to individuals who satisfy
sub. (3).
252.17
252.17
Medical leave premium subsidies.
